Enhancer-targeted CRISPR-A rescues haploinsufficiency and mutant phenotypes in organoid models of autism
Open Access
- 13 November 2026
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- p. 1-14
Abstract
Autism spectrum disorder (ASD) is a highly heritable condition with diverse clinical presentations. Approximately 15% of the genetic susceptibility of ASD is imparted by de novo haploinsufficient mutations of major effect. We mapped enhancers of two high-confidence autism genes, CHD8 and SCN2A , and used CRISPR-based gene activation targeting enhancers (eCRISPR-A) in human pluripotent stem cell (hPSC)-derived excitatory neurons and cerebral forebrain organoids to correct the effects of haploinsufficiency, taking advantage of the presence of a wild-type allele of each gene and endogenous gene regulation. Here we show that eCRISPR-A induced a sustained increase in CHD8 and SCN2A expression specifically in mutant neurons and cortical organoids, with rescue of gene expression levels and mutation-associated phenotypes, including gene expression and physiology. These data support gene activation via targeting enhancers of haploinsufficient genes as a therapeutic intervention in ASD and other neurodevelopmental disorders.Keywords
Funding Information
- National Institute of Mental Health (R01MH10027)
- National Institute of Mental Health (U01MH116489)
- National Institute of Mental Health (F32MH124337)
- Simons Foundation (675474)
- Simons Foundation (675474)
- Simons Foundation (675474)
- Simons Foundation (896724)
- Simons Foundation (896724)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103557)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103557)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD103557)
- Eagles Autism Foundation, pilot grant
This publication has 71 references indexed in Scilit:
- Heterozygous deletion of the autism-associated gene CHD8 impairs synaptic function through widespread changes in gene expression and chromatin compactionThe American Journal of Human Genetics, 2023
- Contemplating syndromic autismGenetics in Medicine, 2023
- Challenges and opportunities for precision medicine in neurodevelopmental disordersAdvanced Drug Delivery Reviews, 2022
- A cross-disorder dosage sensitivity map of the human genomeCell, 2022
- Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of AutismCell, 2020
- Genetic Control of Expression and Splicing in Developing Human Brain Informs Disease MechanismsCell, 2019
- Inherited and De Novo Genetic Risk for Autism Impacts Shared NetworksCell, 2019
- The Dynamic Landscape of Open Chromatin during Human Cortical NeurogenesisCell, 2018
- Disruptive CHD8 Mutations Define a Subtype of Autism Early in DevelopmentCell, 2014
- Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in AutismCell, 2013